Skip to main content
PBLS logo

PBLS · Parabilis Medicines, Inc. · Analyst Estimates

Track PBLS — free
$30.55 -1.74 (-5.39%)
Market Cap
$3.85B
Shares
123.53M
Volume · Oct 1 885.86K Avg daily vol (3M) 640.73K

Analyst Estimates

Compare analyst forecasts for Parabilis Medicines, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-09-18 03:30 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.09
-2.57667
-1.63
—
-1.66
0.0
-1.66
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
1
0
0
Revenue
USD
Publication date not stated
0
1033330
3100000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-3.37
-2.18667
-1.19
—
-1.9
0.0
-1.9
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
1
1
1
Revenue
USD
Publication date not stated
0
3333330
10000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
3
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.45
-0.38
-0.25
—
-0.36667
0.0
-0.36667
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
0
0
Revenue
USD
Publication date not stated
0
500000
1000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
USD
Publication date not stated
-0.47
-0.39667
-0.26
—
-0.37667
0.0
-0.37667
0.0
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
0
0
Revenue
USD
Publication date not stated
0
1000000
2000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
2
— — — — — — — —
Key facts CIK 1657677 CUSIP 698955101 Visit website Investor relations